{"paper_id":"03693a67-7723-46fc-8370-c6715c046a87","body_text":"Акушерство, гинекология и репродукция (Jun 2016)\nELIMINATION OF CHRONIC PELVIC PAIN CAUSED BY ADENOMYOSIS THE PROGESTOGENS NEW GENERATION\nAbstract\nEndometriosis, with more than centenary history, remains a challenge in our day. One of the more common options is adenomyosis, the share of which amounts to 80%. The aim of the study was to evaluate the clinical effectiveness and tolerance to resolve with chronic pelvic pain syndrome of adenomyosis the use of progestogen-new generation dienogest in a dose of 2 mg for 6 months. The study included 44 (n=44) women of reproductive age with a diagnosis of adenomyosis with chronic pelvic pain syndrome of various degrees of severity, whose average age was on average 36 yo 2 years who received therapy with dienogest in a daily dose of 2 mg for 6 months. The results showed high therapeuticefficiency dienogest in the treatment of pelvic pain caused by adenomyosis.","source_license":"CC0","license_restricted":false}